Puma Biotechnology Reports Third Quarter 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
Puma Biotech (PBYI) Tops Q3 EPS by 10c; Offers FY23 Revenue Guidance
November 2, 2023 4:55 PM EDTPuma Biotech (NASDAQ: PBYI) reported Q3 EPS of $0.18, $0.10 better than the analyst estimate of $0.08. Revenue for the quarter came in at $56.1 million versus the consensus estimate of $57.95 million.
GUIDANCE:
Puma Biotech sees FY2023 revenue of $206-209 million, versus the consensus... More
